| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/18/2007 | CN100998625A Medicine for treating calculosis |
| 07/18/2007 | CN100998624A Method for quality control of medicine containing swertia psedochinensis and milk thistle silybum marianum |
| 07/18/2007 | CN100998618A Method for continuously extracting sea-buckthorn oil and sea buckthorn flavonoid by using supercritical CO2 fluid |
| 07/18/2007 | CN100998593A Stable omeprazol sodium preparation for injection |
| 07/18/2007 | CN100998592A Microemulsion containing matrine |
| 07/18/2007 | CN100998584A Medicine composition used for injection and its preparing method |
| 07/18/2007 | CN100998583A Novel use of Bitai-en for protecting liver stem cell, eliminating apoptosis of said cells and protecting nepatic function |
| 07/18/2007 | CN100998576A Pharmaceutical preparation containing zinc baicalin |
| 07/18/2007 | CN100998570A Oral patches containing pdacrilin resin composition and its preparing method |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998561A Biphenyl diester emulsion and its preparing method |
| 07/18/2007 | CN100998552A Composition of oral medicine preparation and its preparing method |
| 07/18/2007 | CN100998426A Method for improving quality of fish meat by adding chitin |
| 07/18/2007 | CN100998412A Health-care food for preventing and treating senile constipation |
| 07/18/2007 | CN100998409A Raw material for making health-care food with functions of tonifying, refreshing and lowering user's weight and its product |
| 07/18/2007 | CN100998406A Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method |
| 07/18/2007 | CN100998403A Composite nutrition nourishing containing Chinese wolfberry |
| 07/18/2007 | CN100998388A Nutrient porridge and its production method |
| 07/18/2007 | CN100998387A Process for processing instant glutinous rice food |
| 07/18/2007 | CN100998371A Feed additive containing the fruit of Chinese wolfberry |
| 07/18/2007 | CN100998362A Chewing gum containing cranberry composition |
| 07/18/2007 | CN100998354A Heath-preserving milk for middle-aged and old people, and its preparing method |
| 07/18/2007 | CN100998313A Production method of ginseng culture root extraction with high content of ginsenoside and its use |
| 07/17/2007 | US7244861 Insulin sensitizer; antidiabetic agents; antiproliferative agents; antiinflammatory agents |
| 07/17/2007 | US7244849 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease |
| 07/17/2007 | US7244846 Substituted benzofuran-2-carboxamides derivatives |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | US7244425 Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol |
| 07/17/2007 | US7244424 Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2300339C Transdermal therapeutic system containing the active substance scopolamine base |
| 07/17/2007 | CA2283198C Butyrate prodrugs derived from lactic acid |
| 07/17/2007 | CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/13/2007 | CA2573879A1 Anti-diarrhea preparations for small domestic animals |
| 07/12/2007 | WO2007079214A2 Prokineticin 2 receptor antagonists |
| 07/12/2007 | WO2007079000A2 Kit comprising an osmotic laxative and a stimulant laxative for prepariing the colon for virtual colonoscopy |
| 07/12/2007 | WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 07/12/2007 | WO2007077893A1 Therapeutic agent for liver disease and hepatic function-ameliorating agent |
| 07/12/2007 | WO2007077656A1 Liquid medicine for internal use |
| 07/12/2007 | WO2007077510A2 Muscarinic receptor antagonists |
| 07/12/2007 | WO2007077210A1 Probiotic oral health promoting product |
| 07/12/2007 | WO2007077158A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
| 07/12/2007 | WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof |
| 07/12/2007 | WO2007076699A1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparing process and application |
| 07/12/2007 | WO2007027548A9 Methods of modulating intestinal fluid balance |
| 07/12/2007 | WO2007026218A3 Chromane substituted 2-alkyl imidazopyridine derivatives and use thereof as acid pump antagonists |
| 07/12/2007 | WO2007019888A3 Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases |
| 07/12/2007 | WO2006110406A3 Compositions comprising probiotic and sweetener components |
| 07/12/2007 | WO2006091795A3 METHODS AND COMPOSITIONS INVOLVING EXPRESSION OF α1C SUBUNIT OF L-TYPE CALCIUM CHANNELS IN SMOOTH MUSCLE CELLS |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161682 Using 2-(((-4-x, 3,5-dimethylpyridin-2-yl)methylthio)5-methoxy-1H-benzimidazole where x is a leaving group; oxidation using titanium complex catalyst and base |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161549 Glycosylation-deficient hepatocyte growth factor |
| 07/12/2007 | US20070161065 DIAGNOSIS, PREVENTION AND TREATMENT OF CROHN'S DISEASE USING THE OmpC ANTIGEN |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160694 Preventives or remedies for tumor or human papillomaviral disease |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160558 Peptide composition |
| 07/12/2007 | DE102006001199A1 Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans Fixed combination of substances with the addition of defoamers for use as Darmspüllösung and / or laxative |
| 07/12/2007 | DE102006001017A1 Use of glucose isomerase in combination with 5-D-fructose dehydrogenase and an enzyme, e.g. invertase, for producing a pharmaceutical composition for preventing, treating, or diagnosing diabetes |
| 07/12/2007 | CA2636236A1 Probiotic oral health promoting product |
| 07/12/2007 | CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved |
| 07/12/2007 | CA2635845A1 Prokineticin 2 receptor antagonists |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2635610A1 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
| 07/12/2007 | CA2635335A1 Muscarinic receptor antagonists |
| 07/11/2007 | EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent |
| 07/11/2007 | EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806134A1 Agent and food for preventing/improving functional digestive disorder |
| 07/11/2007 | EP1805177A1 Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereof |
| 07/11/2007 | EP1804799A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 07/11/2007 | EP1804787A2 Flavonoid composition for treating oral diseases |
| 07/11/2007 | EP1804784A1 The treatment of inflammatory bowel disease |
| 07/11/2007 | EP1804782A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 07/11/2007 | EP1461361B1 Negatively charged polysaccharide derivable from aloe vera |
| 07/11/2007 | EP1455808B1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | EP0808367B1 Mucosal vascular addressins and uses thereof |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1995059A 18alpha glycyrrhizin derivative with amino acid, its preparation method and uses |